Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

FDA reviewing Sun's psoriasis candidate tildrakizumab

June 1, 2017 9:00 PM UTC

Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA) said FDA accepted for review a BLA for tildrakizumab (MK-3222) to treat moderate to severe plaque psoriasis. The company declined to disclose the PDUFA date.

In March, EMA validated an MAA for the product in the indication (see BioCentury, April 3)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article